RxDoctor Payments Data

Jeffrey Christensen, DPM

Foot & Ankle Surgery · Everett, WANPI 1154396901

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $603,424 of the $827,508 with a category attached, or 72.9%. Paragon 28, Inc. accounts for 99.8% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $223,292 and has fallen 77.5% since, to $50,342 in 2025. Among foot & ankle surgery clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$827,508in general payments, 2019–2025

Across 340 payments — averaging $2433.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragon 28, Inc.$826K
  • Treace Medical Concepts, Inc.$295
  • Stryker$231
  • Axogen$150
  • Encore Medical, LP$148
  • Avita Medical Americas, LLC$145
  • plus $382 from 7 others
$16,350in research payments, 2019–2025

Across 6 payments — averaging $2725.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Paragon 28, Inc.$16K
$50,000in ownership & investment interests, 2019–2025

Across 9 payments — averaging $5555.56 each. An ownership or investment interest held by the physician or an immediate family member.

  • Gramercy Extremity Orthopedics LLC$50K
  • Paragon 28, Inc.$0

What the payments were for

  • Royalty or licence$146,63918%
  • Consulting fees$603,42473%
  • Speaking & faculty fees$6950%
  • Travel & lodging$63,5698%
  • Food & beverage$13,1802%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$827,508 in reported general payments places this provider in the 95th percentile of 203 foot & ankle surgery providers in Washington.

See all foot & ankle surgery providers in Washington

Medicare billing

Part B allowed, 2024
$38,994
Medicare patients
81
Services billed
294

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin49$561
Diclofenac Sodium ErDiclofenac Sodium15$459
Oxycodone Hcl16$108
Amoxicillin21$12

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Everett

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →